肝脏肿瘤的 SBRT 治疗：介入放射医师须知。

IF 1 4区医学 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Seminars in Interventional Radiology Pub Date : 2024-03-14 eCollection Date: 2024-02-01 DOI:10.1055/s-0043-1778657

Michael J Gutman, Lucas M Serra, Matthew Koshy, Rohan R Katipally

{"title":"肝脏肿瘤的 SBRT 治疗：介入放射医师须知。","authors":"Michael J Gutman, Lucas M Serra, Matthew Koshy, Rohan R Katipally","doi":"10.1055/s-0043-1778657","DOIUrl":null,"url":null,"abstract":"This review summarizes the clinical evidence supporting the utilization of stereotactic body radiotherapy (SBRT) for liver tumors, including hepatocellular carcinoma, liver metastases, and cholangiocarcinoma. Emerging prospective evidence has demonstrated the benefit and low rates of toxicity across a broad range of clinical contexts. We provide an introduction for the interventional radiologist, with a discussion of underlying themes such as tumor dose-response, mitigation of liver toxicity, and the technical considerations relevant to performing liver SBRT. Ultimately, we recommend that SBRT should be routinely included in the armamentarium of locoregional therapies for liver malignancies, alongside those liver-directed therapies offered by interventional radiology.","PeriodicalId":48689,"journal":{"name":"Seminars in Interventional Radiology","volume":"41 1","pages":"1-10"},"PeriodicalIF":1.0000,"publicationDate":"2024-03-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940045/pdf/","citationCount":"0","resultStr":"{\"title\":\"SBRT for Liver Tumors: What the Interventional Radiologist Needs to Know.\",\"authors\":\"Michael J Gutman, Lucas M Serra, Matthew Koshy, Rohan R Katipally\",\"doi\":\"10.1055/s-0043-1778657\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"This review summarizes the clinical evidence supporting the utilization of stereotactic body radiotherapy (SBRT) for liver tumors, including hepatocellular carcinoma, liver metastases, and cholangiocarcinoma. Emerging prospective evidence has demonstrated the benefit and low rates of toxicity across a broad range of clinical contexts. We provide an introduction for the interventional radiologist, with a discussion of underlying themes such as tumor dose-response, mitigation of liver toxicity, and the technical considerations relevant to performing liver SBRT. Ultimately, we recommend that SBRT should be routinely included in the armamentarium of locoregional therapies for liver malignancies, alongside those liver-directed therapies offered by interventional radiology.\",\"PeriodicalId\":48689,\"journal\":{\"name\":\"Seminars in Interventional Radiology\",\"volume\":\"41 1\",\"pages\":\"1-10\"},\"PeriodicalIF\":1.0000,\"publicationDate\":\"2024-03-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10940045/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Seminars in Interventional Radiology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/s-0043-1778657\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/2/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q4\",\"JCRName\":\"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Seminars in Interventional Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/s-0043-1778657","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/1 0:00:00","PubModel":"eCollection","JCR":"Q4","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

摘要

本综述总结了支持利用立体定向体放射治疗（SBRT）治疗肝脏肿瘤（包括肝细胞癌、肝转移瘤和胆管癌）的临床证据。新出现的前瞻性证据表明，在广泛的临床情况下，SBRT 疗效显著且毒性低。我们为介入放射医师做了介绍，讨论了肿瘤剂量反应、减轻肝脏毒性等基本主题，以及实施肝脏 SBRT 的相关技术注意事项。最后，我们建议将 SBRT 常规纳入肝脏恶性肿瘤的局部治疗中，与介入放射学提供的肝脏导向疗法一起使用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

SBRT for Liver Tumors: What the Interventional Radiologist Needs to Know.

This review summarizes the clinical evidence supporting the utilization of stereotactic body radiotherapy (SBRT) for liver tumors, including hepatocellular carcinoma, liver metastases, and cholangiocarcinoma. Emerging prospective evidence has demonstrated the benefit and low rates of toxicity across a broad range of clinical contexts. We provide an introduction for the interventional radiologist, with a discussion of underlying themes such as tumor dose-response, mitigation of liver toxicity, and the technical considerations relevant to performing liver SBRT. Ultimately, we recommend that SBRT should be routinely included in the armamentarium of locoregional therapies for liver malignancies, alongside those liver-directed therapies offered by interventional radiology.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Seminars in Interventional Radiology RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING&nb-

CiteScore

1.90

自引率

7.10%

发文量

期刊介绍： Seminars in Interventional Radiology is a review journal that publishes topic-specific issues in the field of radiology and related sub-specialties. The journal provides comprehensive coverage of areas such as cardio-vascular imaging, oncologic interventional radiology, abdominal interventional radiology, ultrasound, MRI imaging, sonography, pediatric radiology, musculoskeletal radiology, metallic stents, renal intervention, angiography, neurointerventions, and CT fluoroscopy along with other areas. The journal''s content is suitable for both the practicing radiologist as well as residents in training.